Are there socioeconomic disparities in women having discussions on human papillomavirus vaccine with health care providers?

BMC Women's Health

Volumn 12, Issue , 2012, Pages

  Wong, Ker Y ^a   Do, Young K ^a  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; AWARENESS; ETHNICITY; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE PERSONNEL; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; LOWEST INCOME GROUP; SOCIOECONOMICS;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTHCARE DISPARITIES; HUMANS; IMMUNIZATION PROGRAMS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; POVERTY; PROFESSIONAL-PATIENT RELATIONS; SINGAPORE; SOCIAL CLASS; SOCIOECONOMIC FACTORS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 84866937295     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-12-33     Document Type: Article

References (42)

1. Khan MJ, Partridge EE, Wang SS, Schiffman M. Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer 2005, 104(1):61-70. 10.1002/cncr.21129, 15889450.
2. Bleichrodt H, Gafni A. Time preference, the discounted utility model and health. J Heal Econ 1996, 15:49-66.
3. McDougall JA, Madeleine MM, Daling JR, Li CI. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes & Control 2007, 18(10):1175-1186. 10.1007/s10552-007-9056-y, 23213658.
4. Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer 2003, 105(5):687-691. 10.1002/ijc.11141, 12740919.
5. Khan JA, Lan D, Khan RS. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol 2007, 110(1):87-95. 10.1097/01.AOG.0000266984.23445.9c, 17601901.
6. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE. Prevalence of HPV infection among females in the United States. JAMA 2007, 297(8):813-819. 10.1001/jama.297.8.813, 17327523.
7. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189(1):12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F, 10451482.
8. Licht AS, Murphy JM, Hyland AJ, Fix BV, Hawk LW, Mahoney MC. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?. Sex Transm Infect 2010, 86:74-78. 10.1136/sti.2009.037705, 19841004.
9. Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, national immunization survey-adult 2007. Prev Med 2009, 48(5):426-431. 10.1016/j.ypmed.2008.11.010, 19100762.
10. Dempsey A, Cohn L, Dalton V, Ruffin M. Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine 2011, 29(3):528-534. 10.1016/j.vaccine.2010.10.051, 3013617, 21050904.
11. Caskey R, Lindau ST, Alexander GC. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Heal 2009, 45(5):453-462.
12. Hsu YY, Hsu KF, Cheng YM, Fetzer SJ, Chou CY. Health beliefs of Taiwanese women seeking HPV vaccination. Vaccine 2010, 28:4224-4228. 10.1016/j.vaccine.2010.01.063, 20171307.
13. Li J, Li LK, Ma JF, Wei LH, Niyazi M, Li CQ, Xu AD, Wang JB, Liang H, Belinson J, et al. Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine 2009, 27(8):1210-1215. 10.1016/j.vaccine.2008.12.020, 19135493.
14. Daley EM, Vamos CA, Buhi ER, Kolar SK, McDermott RJ, Hernandez N, Fuhrmann HJ. Influences on human papillomavirus vaccination status among female college students. J Women's Health 2010, 19(10):1-7.
15. Black LL, Zimet GD, Short MB, Sturm L, Rosenthal SL. Literature review of human papillomavirus vaccine acceptability among women over 26 years. Vaccine 2009, 27(11):1668-1673. 10.1016/j.vaccine.2009.01.035, 19195491.
16. Gottlieb SL, Brewer NT, Sternberg MR, Smith JS, Ziarnowski K, Liddon N, Markowitz LE. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Heal 2009, 45(5):430-437.
17. Guerry SL, De Rosa CJ, Markowitz LR, Walker S, Liddon N, Kerndt PR, Gottlieb SL. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine 2011, 2011:2011-2011.
18. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2011, 29(5):890-895. 10.1016/j.vaccine.2009.12.063, 20056186.
19. Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, Short MB, Succop PA. Uptake of HPV vaccine: demographics, sexual history and values, parenting style and vaccine attitudes. J Adolesc Heal 2008, 43:239-245.
20. Freed GL, C SJ, Butchart AT, Singer DC, Davis MM. Parental vaccine safety concerns in 2009. Pediatrics 2010, 125(4):654-659. 10.1542/peds.2009-1962, 20194286.
21. Bednarczyk RA, Birkhead GS, Morse DL, Doleyres H, McNutt LA. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine 2011, 29(17):3138-3143. 10.1016/j.vaccine.2011.02.045, 21376797.
22. Cantor D, Coa K, Crystal-Mansour S, Davis T, Dipko S, Sigman R. Health information national trends survey (HINTS) 2007 final report 2009, Bethesda, MD: National Cancer Institute, Retrieved from http://hints.cancer.gov/docs/HINTS2007FinalReport.pdf.
23. Davidoff A, Blumberg L, Nichols L. State health insurance market reforms and access to insurance for high-risk employees. J Heal Econ 2005, 24(4):725-750.
24. Van De Ven Wynand PMM, Praag Bernard MS. The demand for deductibles in private health insurance: A probit model with sample selection. J Econ 1981, 17(2):229-252.
25. Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiology, Biomarkers & Prevention 2009, 18(2):363-372. 10.1158/1055-9965.EPI-08-0418, 23207104.
26. Sambamoorthi U, McAlpine DD. Racial, ethnic, socioeconomic, and access disparities in the use of preventive services among women. Preventive Medicine 2003, 37(5):475-484. 10.1016/S0091-7435(03)00172-5, 14572431.
27. Centers for Disease Control and Prevention Surveillance of health status in minority communities - racial and ethnic approaches to community health across the U. S. (REACH U. S.) risk factor survey, United States, 2009. In Morbidity and mortality weekly report 2011, 60(SS06):1-41. Centers for Disease Control and Prevention.
28. Agency for Healthcare Research and Quality National healthcare disparities report 2010, Agency for Healthcare Research and Quality.
29. Lin SX, Larson E. Does provision of health counseling differ by patient race?. Fam Med 2005, 37(9):650-654.
30. Baig AA, Heisler M. The influence of patient race and socioeconomic status and resident physician gender and specialty on preventive screening. Semin Med Pract 2008, 11:27-35. 2944258, 20871739.
31. Centers for Disease Control and Prevention Consultation to address STD disparities in African American communities 2007, Atlanta: CDC, Retrieved from http://www.cdc.gov/std/general/STDHealthDisparitiesConsultationJune2007.pdf, Centers for Disease Control and Prevention.
32. Hashimoto H, Fukuhara S. The influence of locus of control on preferences for information and decision making. Patient Educ Couns 2004, 55(2):236-240. 10.1016/j.pec.2003.09.010, 15530760.
33. Johnson JD. Cancer-related information seeking 1997, Cresskill, New Jersey: Hampton Press.
34. Czaja R, Manfredi C, Price J. The determinants and consequences of information seeking among cancer patients. J Heal Commun 2003, 8(6):529-562.
35. Lambert SD, Loiselle CG. Health information-seeking behavior. Qual Heal Res 2007, 17(8):1006-1019.
36. Feemster KA, Winters SE, Fiks AG, Kinsman S, Kahn JA. Pediatricians' intention to recommend human papillomavirus (HPV) vaccines to 11- to 12-year-old girls postlicensing. J Adolesc Heal 2008, 43(4):408-411.
37. Ishibashi KL, Koopmans J, Curlin FA, Alexander KA, Ross LF. Paediatricians' attitudes and practices towards HPV vaccination. Acta Pediatr 2008, 97(11):1550-1556.
38. Duval B, Gilca V, McNeil S, Dobson S, Money D, Gemmill IM, Sauvageau C, Lavoie F, Ouakki M. Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs. Vaccine 2007, 25(45):7841-7847. 10.1016/j.vaccine.2007.08.041, 17923173.
39. Barnack JL, Reddy DM, Swain C. Predictors of parents' willingness to vaccinate for human papillomavirus and physicians' intentions to recommend the vaccine. Women's Health Issues 2010, 20(1):28-34. 10.1016/j.whi.2009.08.007, 3503438, 23213623.
40. Chow S-N, Soon R, Park JS, Pancharoen C, Qiao YL, Basu P, Ngan HYS. Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians. Vaccine 2010, 28(22):3809-3817. 10.1016/j.vaccine.2010.03.027, 20347631.
41. Tiro JA, Meissner HI, Kobrin S, Chollette V. What do women in the U. S. know about human papillomavirus and cervical cancer?. Cancer Epidemiol Biomarkers Prev 2007, 16(2):288-294. 10.1158/1055-9965.EPI-06-0756, 17267388.
42. Cui Y, Baldwin SB, Wiley DJ, Fielding JE. Human papillomavirus vaccine among adult women - disparities in awareness and acceptance. Am J Prev Med 2010, 39(6):559-563. 10.1016/j.amepre.2010.08.001, 21084077.